• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

痰液中性粒细胞弹性蛋白酶与支气管扩张症中的微生物群相关。

Sputum neutrophil elastase associates with microbiota and in bronchiectasis.

作者信息

Oriano Martina, Gramegna Andrea, Terranova Leonardo, Sotgiu Giovanni, Sulaiman Imran, Ruggiero Luca, Saderi Laura, Wu Benjamin, Chalmers James D, Segal Leopoldo N, Marchisio Paola, Blasi Francesco, Aliberti Stefano

机构信息

University of Milan, Dept of Pathophysiology and Transplantation, Milan, Italy.

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Internal Medicine Dept, Respiratory Unit and Adult Cystic Fibrosis Center, Milan, Italy.

出版信息

Eur Respir J. 2020 Oct 22;56(4). doi: 10.1183/13993003.00769-2020. Print 2020 Oct.

DOI:10.1183/13993003.00769-2020
PMID:32499333
Abstract

INTRODUCTION

Neutrophilic inflammation is a major driver of bronchiectasis pathophysiology, and neutrophil elastase activity is the most promising biomarker evaluated in sputum to date. How active neutrophil elastase correlates with the lung microbiome in bronchiectasis is still unexplored. We aimed to understand whether active neutrophil elastase is associated with low microbial diversity and distinct microbiome characteristics.

METHODS

An observational, cross-sectional study was conducted at the bronchiectasis programme of the Policlinico Hospital in Milan, Italy, where adults with bronchiectasis were enrolled between March 2017 and March 2019. Active neutrophil elastase was measured on sputum collected during stable state, microbiota analysed through 16S rRNA gene sequencing, molecular assessment of respiratory pathogens carried out through real-time PCR and clinical data collected.

RESULTS

Among 185 patients enrolled, decreasing α-diversity, evaluated through the Shannon entropy (ρ -0.37, p<0.00001) and Pielou's evenness (ρ -0.36, p<0.00001) and richness (ρ -0.33, p<0.00001), was significantly correlated with increasing elastase. A significant difference in median levels of Shannon entropy as detected between patients with neutrophil elastase ≥20 µg·mL (median 3.82, interquartile range 2.20-4.96) neutrophil elastase <20 µg·mL (4.88, 3.68-5.80; p<0.0001). A distinct microbiome was found in these two groups, mainly characterised by enrichment with in the high-elastase group and with in the low-elastase group. Further confirmation of the association of with elevated active neutrophil elastase was found based on standard culture and targeted real-time PCR.

CONCLUSIONS

High levels of active neutrophil elastase are associated to low microbiome diversity and specifically to infection.

摘要

引言

中性粒细胞炎症是支气管扩张病理生理学的主要驱动因素,中性粒细胞弹性蛋白酶活性是迄今为止在痰液中评估的最有前景的生物标志物。在支气管扩张中,活性中性粒细胞弹性蛋白酶与肺部微生物群之间的关系仍未得到探索。我们旨在了解活性中性粒细胞弹性蛋白酶是否与低微生物多样性和独特的微生物群特征相关。

方法

在意大利米兰综合医院的支气管扩张项目中进行了一项观察性横断面研究,2017年3月至2019年3月期间纳入了成年支气管扩张患者。在稳定状态下收集痰液,测量活性中性粒细胞弹性蛋白酶,通过16S rRNA基因测序分析微生物群,通过实时PCR进行呼吸道病原体的分子评估,并收集临床数据。

结果

在纳入的185例患者中,通过香农熵(ρ -0.37,p<0.00001)、皮洛均匀度(ρ -0.36,p<0.00001)和丰富度(ρ -0.33,p<0.00001)评估的α多样性降低与弹性蛋白酶升高显著相关。中性粒细胞弹性蛋白酶≥20μg·mL的患者(中位数3.82,四分位间距2.20 - 4.96)与中性粒细胞弹性蛋白酶<20μg·mL的患者(4.88,3.68 - 5.80;p<0.0001)之间检测到的香农熵中位数水平存在显著差异。在这两组中发现了不同的微生物群,主要特征是高弹性蛋白酶组中 富集,低弹性蛋白酶组中 富集。基于标准培养和靶向实时PCR进一步证实了 与活性中性粒细胞弹性蛋白酶升高的关联。

结论

高水平的活性中性粒细胞弹性蛋白酶与低微生物群多样性相关,特别是与 感染相关。

相似文献

1
Sputum neutrophil elastase associates with microbiota and in bronchiectasis.痰液中性粒细胞弹性蛋白酶与支气管扩张症中的微生物群相关。
Eur Respir J. 2020 Oct 22;56(4). doi: 10.1183/13993003.00769-2020. Print 2020 Oct.
2
Pro-resolving and pro-inflammatory fatty acid-derived mediators in sputum of stable state bronchiectasis patients.稳定期支气管扩张症患者痰液中促消退和促炎脂肪酸衍生介质。
Respir Res. 2022 Dec 20;23(1):363. doi: 10.1186/s12931-022-02301-5.
3
Evaluation of active neutrophil elastase in sputum of bronchiectasis and cystic fibrosis patients: A comparison among different techniques.支气管扩张症和囊性纤维化患者痰液中活性中性粒细胞弹性蛋白酶的评估:不同技术间的比较。
Pulm Pharmacol Ther. 2019 Dec;59:101856. doi: 10.1016/j.pupt.2019.101856. Epub 2019 Oct 15.
4
A point-of-care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation.一种即时中性粒细胞弹性蛋白酶活性检测可识别支气管扩张症严重程度、气道感染和加重风险。
Eur Respir J. 2019 Jun 13;53(6). doi: 10.1183/13993003.00303-2019. Print 2019 Jun.
5
A novel microbiota stratification system predicts future exacerbations in bronchiectasis.一种新的微生物组分层系统可预测支气管扩张症的未来恶化。
Ann Am Thorac Soc. 2014 May;11(4):496-503. doi: 10.1513/AnnalsATS.201310-335OC.
6
Longitudinal assessment of sputum microbiome by sequencing of the 16S rRNA gene in non-cystic fibrosis bronchiectasis patients.通过对非囊性纤维化支气管扩张症患者16S rRNA基因进行测序对痰液微生物组进行纵向评估。
PLoS One. 2017 Feb 7;12(2):e0170622. doi: 10.1371/journal.pone.0170622. eCollection 2017.
7
The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study.支气管扩张症患者的痰微生物组与临床结局:一项前瞻性观察研究。
Lancet Respir Med. 2021 Aug;9(8):885-896. doi: 10.1016/S2213-2600(20)30557-9. Epub 2021 May 4.
8
Neutrophil Elastase Activity Is Associated with Exacerbations and Lung Function Decline in Bronchiectasis.中性粒细胞弹性蛋白酶活性与支气管扩张症的病情加重及肺功能下降相关。
Am J Respir Crit Care Med. 2017 May 15;195(10):1384-1393. doi: 10.1164/rccm.201605-1027OC.
9
The lung microbiome in children with HIV-bronchiectasis: a cross-sectional pilot study.HIV 支气管扩张症患儿的肺部微生物组:一项横断面初步研究。
BMC Pulm Med. 2018 May 22;18(1):87. doi: 10.1186/s12890-018-0632-6.
10
The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial.大环内酯类药物长期治疗对非囊性纤维化支气管扩张症患者呼吸微生物群组成的影响:来自随机、双盲、安慰剂对照 BLESS 试验的分析。
Lancet Respir Med. 2014 Dec;2(12):988-96. doi: 10.1016/S2213-2600(14)70213-9. Epub 2014 Oct 14.

引用本文的文献

1
Efficacy and safety of Qingbu Weijing decoction in treatment stable bronchiectasis: study protocol for a multicenter, double- blind, randomized and placebo-controlled trial.清补卫津汤治疗稳定期支气管扩张症的疗效与安全性:一项多中心、双盲、随机、安慰剂对照试验的研究方案
BMC Complement Med Ther. 2025 Aug 14;25(1):305. doi: 10.1186/s12906-025-05035-1.
2
Dipeptidyl peptidase 1 inhibitors and neutrophilic inflammation in bronchiectasis: a narrative review.二肽基肽酶1抑制剂与支气管扩张症中的中性粒细胞炎症:一项叙述性综述
J Thorac Dis. 2025 Jul 31;17(7):5347-5360. doi: 10.21037/jtd-2025-289. Epub 2025 Jul 8.
3
in bronchiectasis.
在支气管扩张症中。
Eur Respir Rev. 2025 Aug 6;34(177). doi: 10.1183/16000617.0007-2025. Print 2025 Jun.
4
The role of T-helper and T regulatory cells in driving neutrophilic and eosinophilic inflammation in bronchiectasis.辅助性T细胞和调节性T细胞在支气管扩张症中引发嗜中性粒细胞性和嗜酸性粒细胞性炎症方面的作用。
Front Immunol. 2025 Jun 16;16:1598257. doi: 10.3389/fimmu.2025.1598257. eCollection 2025.
5
Dipeptidyl peptidase-1 inhibitors in bronchiectasis.支气管扩张症中的二肽基肽酶-1抑制剂
Eur Respir Rev. 2025 Jun 18;34(176). doi: 10.1183/16000617.0257-2024. Print 2025 Apr.
6
Short-term stability of the sputum microbiota in bronchiectasis and cystic fibrosis.支气管扩张症和囊性纤维化患者痰液微生物群的短期稳定性
ERJ Open Res. 2025 Jun 16;11(3). doi: 10.1183/23120541.00247-2024. eCollection 2025 May.
7
Multi-omics driven biomarker discovery and pathological insights into Pseudomonas aeruginosa pneumonia.多组学驱动的铜绿假单胞菌肺炎生物标志物发现及病理洞察
BMC Infect Dis. 2025 May 24;25(1):745. doi: 10.1186/s12879-025-11119-7.
8
Neutrophilic inflammation in bronchiectasis.支气管扩张症中的中性粒细胞性炎症。
Eur Respir Rev. 2025 Apr 2;34(176). doi: 10.1183/16000617.0179-2024. Print 2025 Apr.
9
Increased Neutrophil Elastase in Affected Lobes of Bronchiectasis and Correlation of Its Levels between Sputum and Bronchial Lavage Fluid.支气管扩张症受累肺叶中性粒细胞弹性蛋白酶增加及其痰液与支气管肺泡灌洗液中水平的相关性
Tuberc Respir Dis (Seoul). 2025 Apr;88(2):399-407. doi: 10.4046/trd.2024.0078. Epub 2025 Jan 14.
10
Targeting neutrophil serine proteases in bronchiectasis.靶向支气管扩张症中的中性粒细胞丝氨酸蛋白酶
Eur Respir J. 2025 Jan 2;65(1). doi: 10.1183/13993003.01050-2024. Print 2025 Jan.